MapLight Therapeutics (MPLT) Income Statement: Revenue & Earnings

MapLight Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

MapLight Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	0.00	0.00	0.00
Cost of Revenue	0.70	0.00	0.00
Gross Profit	-0.70	0.00	0.00
Operating Expenses
Research & Development	67.82	49.68	27.14
Selling, General & Administrative	14.42	7.61	4.10
Operating Expenses	82.25	57.28	31.25
Operating Income	-82.95	-57.28	-31.25
Other Income/Expense
Interest Income	4.50	1.10	0.43
Interest Expense	0.00	0.00	0.00
Other Income/Expense	5.37	-0.51	0.80
Income
Income Before Tax	-77.58	-55.71	-30.02
Income Tax Expense	0.00	0.00	0.00
Net Income	-77.58	-55.71	-30.02
Net Income - Continuous Operations	-77.58	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00
EBITDA	-76.88	-56.73	-30.67
EBIT	-82.95	-57.28	-31.25
Depreciation & Amortization	0.70	0.56	0.57
Earnings Per Share
Basic EPS	-2.00	-84.00	-54.00
Diluted EPS	-2.00	-84.00	-54.00
Basic Shares Outstanding	41.43	0.66	0.56
Diluted Shares Outstanding	41.43	0.66	0.56